GemPharmatech is hosting an annual symposium focused on metabolic disease in San Diego on September 11, 2026, featuring a program exploring obesity, insulin resistance, and cardiometabolic dysfunction.
Published
Signal category
Presence & Recognition
Quote
“In one week, GemPharmatech’s annual symposium, this year focused on #metabolicdisease, will take place in San Diego.”
— GemPharmatech team
Company
GemPharmatech
Accelerating Innovation Through Genetically Engineered Mouse Models (GEMMs) and Preclinical Services
- Industry
- Biotechnology Research
- Location
- San Diego, US
- Company size
- 110 employees
GemPharmatech Co. Ltd., founded in 2017, is an international biotechnology enterprise specializing in the development of humanized animal models. The management and operation team has nearly 20 years of experience in gene-editing technology and animal production. GemPharmatech provides a one-stop service as model customization, breeding, phenotyping, and pharmacology for the biomedical research community. The company has developed the world's most abundant mouse strains resource to inspire scientific innovation and drive drug discovery.
Founded 2017